New PP&P State of Pharmacy Compounding report shows EQUASHIELD ® now accounts for 44% of CSTDs in use for hazardous drug preparation PORT WASHINGTON, N.Y., May 8, 2026 /PRNewswire/ -- In a healthcare ...
PORT WASHINGTON, N.Y., Dec. 3, 2025 /PRNewswire/ -- EQUASHIELD ®, a global leader in Closed System Transfer Devices (CSTD) and pharmacy automation, will highlight its fully integrated hazardous drug ...
PORT WASHINGTON, N.Y., May 13, 2024 /PRNewswire/ -- EQUASHIELD ®, a global leader in the development and distribution of Closed System Transfer Devices (CSTDs) and pharmacy automation solutions, marks ...
Equashield is the first to introduce CSTDs to Romania, helping protect healthcare workers in light of increased demand for chemotherapy drugs PORT WASHINGTON, New ...
PORT WASHINGTON, New York, Nov. 27, 2018 /PRNewswire/ -- Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, today announced it will ...
The recent clearance reconfirms the freedom to utilize the entire volume of EQUASHIELD's Syringe Unit, leading to enhanced cost savings and safety with handling of hazardous drugs. PORT WASHINGTON, ...
Nordic Capital to Advance Achievement of Equashield Strategic Objective of Global Leadership in Hazardous Drug Handling Solutions PORT WASHINGTON, N.Y. , Oct. 7, 2022 /PRNewswire/ -- , a leading ...
NEW YORK, Sept. 8, 2019 /PRNewswire/ -- Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, announced today that, through Japanese ...
Partnership with Saudi Arabia-based Max Care Medical to promote safe handling practice for cytotoxics at upcoming regional conferences: 5th Annual GCC Pharmacy Congress and 4th IVPN Symposium ...